AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2010
Sep 8, 2010
30786_dirs_2010-09-08_77334892-0155-49c0-9eeb-e6b2a2d1fe7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2010-09-03
Reporting Person: SCHWARTZ DAVID (Director, Chairman of the Board, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-09-03 | Bio-Rad B Common Stock | M | 36250 | $11.94 | Acquired | 426640 | Direct |
| 2010-09-07 | Bio-Rad B Common Stock | M | 36250 | $11.94 | Acquired | 462890 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-09-03 | Non-Qualified Stock Option (right to buy) | $11.94 | M | 36250 | Disposed | 2010-09-19 | Bio-Rad B Common Stock (36250) | Direct |
| 2010-09-07 | Non-Qualified Stock Option (right to buy) | $11.94 | M | 36250 | Disposed | 2010-09-19 | Bio-Rad B Common Stock (36250) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 1404588 | Direct |
| Bio-Rad A Common Stock | 825208 | Indirect |
| Bio-Rad A Common Stock | 825208 | Indirect |
| Bio-Rad A Common Stock | 34311 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
| Bio-Rad B Common Stock | 41176 | Indirect |
Footnotes
F1: The shares are held by a limited partnership of which the reporting person is a limited and general partner.
F2: The shares are held by a limited partnership of which the reporting person is a general partner.
F3: The stock option, granted on 9/19/2000, vested over four years at 25% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13